85 related articles for article (PubMed ID: 3929261)
1. Measures to inactivate viral contaminants of pooled plasma products.
Menache D; Aronson DL
Prog Clin Biol Res; 1985; 182():407-23. PubMed ID: 3929261
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, beta-propiolactone, and ultraviolet irradiation.
Prince AM; Stephan W; Kotitschke R; Brotman B
Thromb Haemost; 1983 Aug; 50(2):534-6. PubMed ID: 6415846
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of HTLV-III/LAV, hepatitis B and non-A/non-B viruses by pasteurization in human plasma protein preparations.
Mauler R; Merkle W; Hilfenhaus J
Dev Biol Stand; 1987; 67():337-51. PubMed ID: 3111911
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C, other types of non-B parenteral hepatitis and blood transfusion.
Dodd RY
Dev Biol Stand; 1993; 81():35-40. PubMed ID: 8174817
[TBL] [Abstract][Full Text] [Related]
5. Primate animal models and titered inocula for the study of human hepatitis A, hepatitis B, and non-A, non-B hepatitis.
Tabor E; Purcell RH; Gerety RJ
J Med Primatol; 1983; 12(6):305-18. PubMed ID: 6094814
[TBL] [Abstract][Full Text] [Related]
6. Viral safety of solvent-detergent treated blood products.
Horowitz B; Prince AM; Horowitz MS; Watklevicz C
Dev Biol Stand; 1993; 81():147-61. PubMed ID: 8174797
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-transmitted hepatitis virus infection.
Dodd RY
Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
[TBL] [Abstract][Full Text] [Related]
8. Ways to reduce the risk of transmission of viral infections by plasma and plasma products. A comparison of methods, their advantages and disadvantages.
Vox Sang; 1988; 54(4):228-45. PubMed ID: 3388821
[No Abstract] [Full Text] [Related]
9. non-A, Non-B hepatitis. II. Experimental transmission, putative virus agents and markers, and prevention.
Dienstag JL
Gastroenterology; 1983 Sep; 85(3):743-68. PubMed ID: 6307808
[No Abstract] [Full Text] [Related]
10. Fibrin glue safety: inactivation of potential viral contaminants by pasteurization of the human plasma components.
Hilfenhaus J; Weidmann E
Arzneimittelforschung; 1985; 35(11):1617-9. PubMed ID: 3004516
[TBL] [Abstract][Full Text] [Related]
11. Strategies for the prevention of post-transfusion hepatitis.
Mintz PD
Ann Clin Lab Sci; 1984; 14(3):198-207. PubMed ID: 6428295
[TBL] [Abstract][Full Text] [Related]
12. [Possibilities of virus inactivation of pooled fresh plasma with tri-n-butylphosphate (TNBP) detergents (SD procedure)].
Gürtler L
Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():77-9. PubMed ID: 8000260
[TBL] [Abstract][Full Text] [Related]
13. Viral infections transmitted by blood and its products.
Barbara JA; Tedder RS
Clin Haematol; 1984 Oct; 13(3):693-707. PubMed ID: 6094064
[TBL] [Abstract][Full Text] [Related]
14. H5N1 influenza virus and the safety of plasma products.
Kreil TR; Unger U; Orth SM; Petutschnig G; Kistner O; Poelsler G; Berting A
Transfusion; 2007 Mar; 47(3):452-9. PubMed ID: 17319825
[TBL] [Abstract][Full Text] [Related]
15. Resistance of porcine circovirus and chicken anemia virus to virus inactivation procedures used for blood products.
Welch J; Bienek C; Gomperts E; Simmonds P
Transfusion; 2006 Nov; 46(11):1951-8. PubMed ID: 17076851
[TBL] [Abstract][Full Text] [Related]
16. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
17. [Non-A, non-B hepatitis-related antigens and antibodies and experimental infection].
Yoshizawa H
Rinsho Byori; 1984 Nov; 32(11):1202-12. PubMed ID: 6084080
[No Abstract] [Full Text] [Related]
18. Reducing the risk of infection from plasma products: specific preventative strategies.
Burnouf T; Radosevich M
Blood Rev; 2000 Jun; 14(2):94-110. PubMed ID: 11012252
[TBL] [Abstract][Full Text] [Related]
19. Preventing the spread of hepatitis B and C viruses: where are germicides relevant?
Sattar SA; Tetro J; Springthorpe VS; Giulivi A
Am J Infect Control; 2001 Jun; 29(3):187-97. PubMed ID: 11391281
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis and transfusions.
Donnelly K
Nephrol Nurs J; 2000 Oct; 27(5):538-9. PubMed ID: 16649331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
